NASDAQ:ATEC Alphatec (ATEC) Stock Forecast, Price & News $15.16 +0.32 (+2.16%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$14.78▼$15.3450-Day Range$14.32▼$16.3852-Week Range$5.73▼$17.13Volume939,085 shsAverage Volume1.12 million shsMarket Capitalization$1.80 billionP/E RatioN/ADividend YieldN/APrice Target$16.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Alphatec MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside7.2% Upside$16.25 Price TargetShort InterestBearish10.76% of Float Sold ShortDividend StrengthN/ASustainability-1.67Upright™ Environmental ScoreNews Sentiment0.98Based on 3 Articles This WeekInsider TradingSelling Shares$990.67 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.21) to ($0.88) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.78 out of 5 starsMedical Sector822nd out of 1,006 stocksSurgical & Medical Instruments Industry84th out of 104 stocks 1.4 Analyst's Opinion Consensus RatingAlphatec has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.25, Alphatec has a forecasted upside of 7.2% from its current price of $15.16.Amount of Analyst CoverageAlphatec has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted10.76% of the float of Alphatec has been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in Alphatec has recently decreased by 0.64%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAlphatec does not currently pay a dividend.Dividend GrowthAlphatec does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAlphatec has received a 37.18% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Cervical implants", "Medical screws", and "Lumbar spinal stenosis treatment instruments" products. See details.Environmental SustainabilityThe Environmental Impact score for Alphatec is -1.67. Previous Next 2.8 News and Social Media Coverage News SentimentAlphatec has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Alphatec this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for ATEC on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.MarketBeat Follows7 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alphatec insiders have sold 2,308,618.31% more of their company's stock than they have bought. Specifically, they have bought $42,910.00 in company stock and sold $990,671,025.00 in company stock.Percentage Held by Insiders33.93% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions48.59% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Alphatec are expected to grow in the coming year, from ($1.21) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alphatec is -10.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alphatec is -10.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Alphatec (NASDAQ:ATEC) StockAlphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.Read More Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address ATEC Stock News HeadlinesMay 26, 2023 | msn.comNeedham Reiterates Alphatec Holdings (ATEC) Buy RecommendationMay 26, 2023 | markets.businessinsider.comWhere Alphatec Holdings Stands With AnalystsJune 1, 2023 | Edge On The Street (Ad)The $193 Billion US-China War You Don't Know AboutThey're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.May 23, 2023 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Alphatec Holdings (ATEC)May 18, 2023 | americanbankingnews.comInsider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Sells 58,238 Shares of StockMay 18, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) Research Coverage Started at StockNews.comMay 17, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) Stock Price Down 3.4% After Insider SellingMay 16, 2023 | marketwatch.comInterbody Devices Market 2023 Size, share and Forecast to 2028June 1, 2023 | Edge On The Street (Ad)The $193 Billion US-China War You Don't Know AboutThey're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.May 12, 2023 | americanbankingnews.comAlphatec Holdings, Inc. (NASDAQ:ATEC) Receives $16.25 Average Price Target from BrokeragesMay 12, 2023 | americanbankingnews.comStockNews.com Lowers Alphatec (NASDAQ:ATEC) to SellMay 10, 2023 | msn.comMorgan Stanley Maintains Alphatec Holdings (ATEC) Overweight RecommendationMay 8, 2023 | seekingalpha.comAlphatec: A Balancing ActMay 6, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) vs. Stevanato Group (NYSE:STVN) Financial ContrastMay 4, 2023 | finance.yahoo.comATEC Reports First Quarter 2023 Financial ResultsMay 2, 2023 | americanbankingnews.comAlphatec (ATEC) Set to Announce Earnings on ThursdayApril 26, 2023 | americanbankingnews.comJohn Todd Koning Sells 16,500 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) StockApril 26, 2023 | americanbankingnews.comCraig E. Hunsaker Sells 28,311 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) StockApril 25, 2023 | americanbankingnews.comQ1 2023 Earnings Estimate for Alphatec Holdings, Inc. (NASDAQ:ATEC) Issued By Jefferies Financial GroupApril 22, 2023 | americanbankingnews.comAlphatec (NASDAQ:ATEC) Sees Strong Trading VolumeApril 21, 2023 | americanbankingnews.comJefferies Financial Group Comments on Alphatec Holdings, Inc.'s Q2 2023 Earnings (NASDAQ:ATEC)April 20, 2023 | americanbankingnews.comNeedham & Company LLC Reaffirms Buy Rating for Alphatec (NASDAQ:ATEC)April 18, 2023 | markets.businessinsider.comAlphatec Holdings (ATEC) Receives a Buy from NeedhamApril 17, 2023 | americanbankingnews.comAnalysts Set Alphatec Holdings, Inc. (NASDAQ:ATEC) Target Price at $16.25April 15, 2023 | marketwatch.comAircraft VHF Radios Market Forecast to 2031April 15, 2023 | finance.yahoo.comATEC- A Spinal Surgery Pure Play Whose Sales are SurgingApril 10, 2023 | marketwatch.com2023 Prestige Cervical Disc Market Size Predicted to Boost Growth and Demand by 2030See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address ATEC Company Calendar Last Earnings11/04/2021Today5/31/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:ATEC CUSIP02081G10 CIK1350653 Webwww.atecspine.com Phone(760) 431-9286Fax800-922-1356Employees561Year Founded1990Price Target and Rating Average Stock Price Forecast$16.25 High Stock Price Forecast$20.00 Low Stock Price Forecast$9.50 Forecasted Upside/Downside+7.2%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-152,150,000.00 Net Margins-39.28% Pretax Margin-39.28% Return on Equity-575.45% Return on Assets-28.96% Debt Debt-to-Equity RatioN/A Current Ratio2.09 Quick Ratio1.34 Sales & Book Value Annual Sales$350.87 million Price / Sales5.12 Cash FlowN/A Price / Cash FlowN/A Book Value($0.49) per share Price / Book-30.94Miscellaneous Outstanding Shares118,500,000Free Float78,291,000Market Cap$1.80 billion OptionableNot Optionable Beta1.25 Social Links Key ExecutivesPatrick S. MilesChairman, President, CEO & COOJ. Todd KoningChief Financial Officer & Executive Vice PresidentScott LishSenior Vice President-Research & DevelopmentKelli M. HowellExecutive Vice President-Clinical StrategiesLuiz PimentaChief Medical OfficerKey CompetitorsNuVasiveNASDAQ:NUVAAtriCureNASDAQ:ATRCCardiovascular SystemsNASDAQ:CSIIOrthofix MedicalNASDAQ:OFIXIntegra LifeSciencesNASDAQ:IARTView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Sold 6,049 shares on 5/22/2023Ownership: 0.027%JPMorgan Chase & Co.Sold 259,563 shares on 5/18/2023Ownership: 1.529%First Light Asset Management LLCBought 17,952 shares on 5/16/2023Ownership: 2.485%Mercer Global Advisors Inc. ADVBought 686 shares on 5/16/2023Ownership: 0.293%Front Row Advisors LLCSold 2,953 shares on 5/16/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions ATEC Stock - Frequently Asked Questions Should I buy or sell Alphatec stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ATEC shares. View ATEC analyst ratings or view top-rated stocks. What is Alphatec's stock price forecast for 2023? 6 brokers have issued 12-month price objectives for Alphatec's stock. Their ATEC share price forecasts range from $9.50 to $20.00. On average, they expect the company's share price to reach $16.25 in the next year. This suggests a possible upside of 7.2% from the stock's current price. View analysts price targets for ATEC or view top-rated stocks among Wall Street analysts. How have ATEC shares performed in 2023? Alphatec's stock was trading at $12.35 at the start of the year. Since then, ATEC shares have increased by 22.8% and is now trading at $15.16. View the best growth stocks for 2023 here. When is Alphatec's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our ATEC earnings forecast. How were Alphatec's earnings last quarter? Alphatec Holdings, Inc. (NASDAQ:ATEC) announced its quarterly earnings results on Thursday, November, 4th. The medical technology company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.20. The medical technology company had revenue of $62.88 million for the quarter, compared to analysts' expectations of $61.43 million. Alphatec had a negative trailing twelve-month return on equity of 575.45% and a negative net margin of 39.28%. During the same period in the prior year, the business earned ($0.18) EPS. What ETFs hold Alphatec's stock? ETFs with the largest weight of Alphatec (NASDAQ:ATEC) stock in their portfolio include Jacob Forward ETF (JFWD), Invesco DWA Healthcare Momentum ETF (PTH), SPDR S&P Health Care Equipment ETF (XHE), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Invesco Nasdaq Future Gen 200 ETF (QQQS), Principal Healthcare Innovators ETF (BTEC), Global X Aging Population ETF (AGNG) and iShares Micro-Cap ETF (IWC). What guidance has Alphatec issued on next quarter's earnings? Alphatec issued an update on its first quarter 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $108.00 million-$109.50 million, compared to the consensus revenue estimate of $101.59 million. What is Pat Miles' approval rating as Alphatec's CEO? 19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend. What other stocks do shareholders of Alphatec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alphatec investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), Sorrento Therapeutics (SRNE), Catalyst Pharmaceuticals (CPRX), (GBSN) (GBSN), Idera Pharmaceuticals (IDRA), Athersys (ATHX), Anavex Life Sciences (AVXL) and BioCryst Pharmaceuticals (BCRX). What is Alphatec's stock symbol? Alphatec trades on the NASDAQ under the ticker symbol "ATEC." Who are Alphatec's major shareholders? Alphatec's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include First Light Asset Management LLC (2.48%), Next Century Growth Investors LLC (1.78%), State Street Corp (1.62%), Cerity Partners LLC (1.57%), JPMorgan Chase & Co. (1.53%) and Geode Capital Management LLC (1.23%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish. View institutional ownership trends. How do I buy shares of Alphatec? Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Alphatec's stock price today? One share of ATEC stock can currently be purchased for approximately $15.16. How much money does Alphatec make? Alphatec (NASDAQ:ATEC) has a market capitalization of $1.80 billion and generates $350.87 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis. How many employees does Alphatec have? The company employs 561 workers across the globe. How can I contact Alphatec? Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356. This page (NASDAQ:ATEC) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.